Clinical Trials in Chronic Liver Disease - What Do They Achieve?
The past 30 years have seen rapid growth in the number of clinical trials in liver disease; due mostly to effective drug discovery programs by the pharmaceutical industry. The advantages associated with therapeutic trials in chronic liver disease, or any other disease for that matter, go far bey...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2004-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2004/748749 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558736374235136 |
|---|---|
| author | Jenny Heathcote |
| author_facet | Jenny Heathcote |
| author_sort | Jenny Heathcote |
| collection | DOAJ |
| description | The past 30 years have seen rapid growth in the number of clinical trials in liver disease; due mostly to effective drug discovery programs by the pharmaceutical industry. The advantages associated with therapeutic trials in chronic liver disease, or any other disease for that matter, go far beyond potential benefit to the individual patient, other beneficiaries include the treating physician, the sponsoring agency and their investors, the institution/university and the general public. But there is always a downside to any experiment. The disadvantages and advantages of clinical trials in liver disease are the topics for this discussion. |
| format | Article |
| id | doaj-art-82e38746225d489a86a9572c86d6d711 |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2004-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-82e38746225d489a86a9572c86d6d7112025-02-03T01:31:37ZengWileyCanadian Journal of Gastroenterology0835-79002004-01-0118848949210.1155/2004/748749Clinical Trials in Chronic Liver Disease - What Do They Achieve?Jenny HeathcoteThe past 30 years have seen rapid growth in the number of clinical trials in liver disease; due mostly to effective drug discovery programs by the pharmaceutical industry. The advantages associated with therapeutic trials in chronic liver disease, or any other disease for that matter, go far beyond potential benefit to the individual patient, other beneficiaries include the treating physician, the sponsoring agency and their investors, the institution/university and the general public. But there is always a downside to any experiment. The disadvantages and advantages of clinical trials in liver disease are the topics for this discussion.http://dx.doi.org/10.1155/2004/748749 |
| spellingShingle | Jenny Heathcote Clinical Trials in Chronic Liver Disease - What Do They Achieve? Canadian Journal of Gastroenterology |
| title | Clinical Trials in Chronic Liver Disease - What Do They Achieve? |
| title_full | Clinical Trials in Chronic Liver Disease - What Do They Achieve? |
| title_fullStr | Clinical Trials in Chronic Liver Disease - What Do They Achieve? |
| title_full_unstemmed | Clinical Trials in Chronic Liver Disease - What Do They Achieve? |
| title_short | Clinical Trials in Chronic Liver Disease - What Do They Achieve? |
| title_sort | clinical trials in chronic liver disease what do they achieve |
| url | http://dx.doi.org/10.1155/2004/748749 |
| work_keys_str_mv | AT jennyheathcote clinicaltrialsinchronicliverdiseasewhatdotheyachieve |